Literature DB >> 6869178

Ventricular fibrillation following verapamil in the Wolff-Parkinson-White syndrome.

S Gulamhusein, P Ko, G J Klein.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6869178     DOI: 10.1016/0002-8703(83)90452-0

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


× No keyword cloud information.
  6 in total

Review 1.  Drug effects on the electrocardiogram. A review of their clinical importance.

Authors:  J D Symanski; L S Gettes
Journal:  Drugs       Date:  1993-08       Impact factor: 9.546

Review 2.  Digitalis and verapamil in atrial fibrillation and flutter. Is verapamil now the preferred agent?

Authors:  H O Klein; E Kaplinsky
Journal:  Drugs       Date:  1986-03       Impact factor: 9.546

3.  Acceleration of the ventricular response to atrial flutter by amiodarone in an infant with Wolff-Parkinson-White syndrome.

Authors:  J A Till; M Baxendall; A Benetar
Journal:  Br Heart J       Date:  1993-07

Review 4.  A review of atrial fibrillation.

Authors:  David Dang; Raluca Arimie; L Julian Haywood
Journal:  J Natl Med Assoc       Date:  2002-12       Impact factor: 1.798

5.  Management of elderly patients with the Wolff-Parkinson-White syndrome: is less aggressive treatment justified?

Authors:  G Heinz; G Kreiner; S Radosztics; P Siostrzonek; H Gössinger
Journal:  Clin Investig       Date:  1993-07

6.  Deleterious effects of intravenous verapamil in Wolff-Parkinson-White patients and atrial fibrillation.

Authors:  B Strasberg; A Sagie; E Rechavia; A Katz; I A Ovsyscher; S Sclarovsky; J Agmon
Journal:  Cardiovasc Drugs Ther       Date:  1989-01       Impact factor: 3.727

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.